Editorial: (New Drug (LCZ696) for the Treatment of Heart Failure with Reduced Ejection Fraction After 10 Years. Can One Study Change the Guidelines?) | Bentham Science Publishers

2000

Volume 12, Issue 6

ISSN: 1570-1611
E-ISSN: 1875-6212

oa Editorial: (New Drug (LCZ696) for the Treatment of Heart Failure with Reduced Ejection Fraction After 10 Years. Can One Study Change the Guidelines?)
By Vasilios G. Athyros, Niki Katsiki and Asterios Karagiannis
Source: Current Vascular Pharmacology, Volume 12, Issue 6, Nov 2014, p. 867 - 869
DOI: https://doi.org/10.2174/157016111206141210114716
- Available online: 01 Nov 2014

Preview this article:

There is no abstract available.

© Bentham Science Publishers

Article metrics loading...

/content/journals/cvp/10.2174/157016111206141210114716

2014-11-01

2025-01-10

From This Site

/content/journals/cvp/10.2174/157016111206141210114716

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Loading full text...

Full text loading...

/content/journals/cvp/10.2174/157016111206141210114716

Article Type: Research Article

Keyword(s): AHU-377; Heart failure with reduced ejection fraction; hospitalization; LCZ696; survival; valsartan

Most Cited Most Cited RSS feed

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test